Alerts
Breast Cancer Radiation De-Escalation Has an Adherence Problem
Real-world data presented at ASTRO show that fewer than three in ten women remained adherent to endocrine therapy over five years after lumpectomy, and omission of radiotherapy was associated with poorer adherence. De-escalation works only if the treatment patients are supposed to keep taking is actually taken.
Personalised Cancer Vaccines Show Longer-Term Staying Power
China’s PD-1/VEGF Bet Challenges the Lung Cancer Backbone
High-Risk Prostate Cancer Moves Before the Metastatic Clock Starts
Servier’s $2.65B Muscular Dystrophy Deal Turns Rare Neurology Into a Commercial Priority
Lenacapavir Turns HIV Prevention Into an Access Stress Test
WHO’s New AMR Plan Makes Stewardship and Access a Single Test
Can cortisol become the next target in type 2 diabetes?
An ADC Steps Into the First-Line Gap in Triple-Negative Breast Cancer
Alpha Radioligand Therapy Moves Prostate Cancer Into a New Infrastructure Test
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.